![Elisabeth Leiderman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elisabeth Leiderman
Direktor/Vorstandsmitglied bei
AUTOLUS THERAPEUTICS PLC
Vermögen: - $ am 31.05.2026
Profil
Elisabeth Leiderman is currently Non-Executive Director at Autolus Therapeutics Plc since 2023 and Chief Financial Officer at Dewpoint Therapeutics, Inc. starting in 2024.
Former roles include Independent Director at Genetix Biotherapeutics, Inc. from 2021 to 2025, Chief Financial & Business Officer at Atsena Therapeutics, Inc. from 2022 to 2023, Chief Financial & Accounting Officer at Decibel Therapeutics, Inc. from 2021 to 2022, Chief Business Officer at Complexa, Inc. from 2016 to 2020, Executive Director at Nomura Securities, Inc. from 2013 to 2016, and VP-Business & Corporate Development at Fortress Biotech, Inc. from 2007 to 2016.
Education includes undergraduate studies at the University of Pennsylvania, an MBA from The Wharton School of the University of Pennsylvania, and a doctorate from Sackler School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Elisabeth Leiderman
| Unternehmen | Position | Beginn |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 20.12.2023 |
Dewpoint Therapeutics, Inc.
 Dewpoint Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biomolecular condensates biotechnology company | Finanzdirektor/CFO | 01.06.2024 |
Ehemalige bekannte Positionen von Elisabeth Leiderman
| Unternehmen | Position | Ende |
|---|---|---|
| GENETIX BIOTHERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 02.06.2025 |
Atsena Therapeutics, Inc.
 Atsena Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical-stage gene therapy company that develops treatments for inherited retinal diseases that cause blindness | Finanzdirektor/CFO | 01.11.2023 |
| DECIBEL THERAPEUTICS, INC. | Finanzdirektor/CFO | 07.10.2022 |
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on discovering and developing therapies for the treatment inflammatory and metabolic diseases | Corporate Officer/Principal | 01.08.2020 |
Nomura Securities, Inc. | Direktor/Vorstandsmitglied | 01.07.2016 |
Ausbildung von Elisabeth Leiderman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
39
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Fortress Biotech, Inc.
 Fortress Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and biotechnology products | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on discovering and developing therapies for the treatment inflammatory and metabolic diseases | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sackler School of Medicine
 Sackler School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Decibel Therapeutics, Inc.
 Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biomolecular condensates biotechnology company | Health Technology |
Atsena Therapeutics, Inc.
Atsena Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical-stage gene therapy company that develops treatments for inherited retinal diseases that cause blindness | Health Technology |
Nomura Securities, Inc. |
